ArticlePediatric blood & cancer2024

Eculizumab for management of hyperhemolysis syndrome in pediatric patients with sickle cell disease: A single-center case series.

Ajibike Lapite et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.